Antibiotic Development Incentives Face Critical Test As NDA Reviews Begin
Law has encouraged FDA to be flexible on data requirements for antibiotics, according to sponsors.
Law has encouraged FDA to be flexible on data requirements for antibiotics, according to sponsors.